Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2023-04-01
|
| Series: | Pain and Therapy |
| Online Access: | https://doi.org/10.1007/s40122-023-00502-4 |
| _version_ | 1797823045031690240 |
|---|---|
| author | David Chandler Christine Szekely Shivani Aggarwal Lori Cyprien Mark Bensink |
| author_facet | David Chandler Christine Szekely Shivani Aggarwal Lori Cyprien Mark Bensink |
| author_sort | David Chandler |
| collection | DOAJ |
| first_indexed | 2024-03-13T10:18:15Z |
| format | Article |
| id | doaj.art-e33a43bd37524d8dba7531eef5732027 |
| institution | Directory Open Access Journal |
| issn | 2193-8237 2193-651X |
| language | English |
| last_indexed | 2024-03-13T10:18:15Z |
| publishDate | 2023-04-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Pain and Therapy |
| spelling | doaj.art-e33a43bd37524d8dba7531eef57320272023-05-21T11:07:50ZengAdis, Springer HealthcarePain and Therapy2193-82372193-651X2023-04-0112388988910.1007/s40122-023-00502-4Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims DataDavid Chandler0Christine Szekely1Shivani Aggarwal2Lori Cyprien3Mark Bensink4Global Health Economics, Amgen Inc.Center for Observational Research, Amgen Inc.Center for Observational Research, Amgen Inc.Center for Observational Research, Amgen Inc.Global Health Economics, Amgen Inc.https://doi.org/10.1007/s40122-023-00502-4 |
| spellingShingle | David Chandler Christine Szekely Shivani Aggarwal Lori Cyprien Mark Bensink Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data Pain and Therapy |
| title | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_full | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_fullStr | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_full_unstemmed | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_short | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_sort | correction to migraine characteristics comorbidities healthcare resource utilization and associated costs of early users of erenumab in the usa a retrospective cohort study using administrative claims data |
| url | https://doi.org/10.1007/s40122-023-00502-4 |
| work_keys_str_mv | AT davidchandler correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT christineszekely correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT shivaniaggarwal correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT loricyprien correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT markbensink correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata |